Mercado global de dispositivos de mamografia – Tendências do setor e previsão para 2031

Análise e dimensão do mercado de dispositivos de mamografia

De acordo com o relatório Globocan de 2022, o cancro da mama destaca-se como o segundo cancro mais diagnosticado a nível mundial, constituindo 11,6% de todos os casos de cancro a nível mundial. Esta prevalência generalizada serve como o principal motor para o crescimento do mercado de dispositivos de mamografia. Os dispositivos de mamografia desempenham um papel fundamental no domínio da imagiologia médica, concebidos especificamente para a detecção precoce e o diagnóstico preciso do cancro da mama. A elevada taxa de incidência exige programas de rastreio frequentes e generalizados, aumentando a procura de dispositivos de mamografia nas unidades de saúde de todo o mundo. Estes dispositivos são ferramentas essenciais para a detecção precoce, permitindo aos prestadores de cuidados de saúde identificar o cancro da mama nas suas fases iniciais e mais tratáveis.

O tamanho do mercado global de dispositivos de mamografia foi avaliado em 2,31 mil milhões de dólares em 2023 e deverá atingir os 5,68 mil milhões de dólares até 2031, com um CAGR de 11,9% durante o período de previsão de 2024 a 2031. Para além dos insights sobre cenários de mercado, tais como o valor do mercado, a taxa de crescimento, a segmentação, a cobertura geográfica e os grandes players, os relatórios de mercado com curadoria da Data Bridge Market Research incluem também análises especializadas aprofundadas, epidemiologia de pacientes, análise de pipeline, análise de preços e a estrutura regulatória.

Âmbito do relatório e segmentação de mercado       

Definição de mercado

Mammography devices are specialized medical imaging systems used for the early detection and diagnosis of breast cancer. These devices utilize low-dose X-rays to create detailed images of the breast tissue, known as mammograms, which can reveal abnormal growths or changes in breast tissue. Mammography devices include film screen systems, digital systems, 3D systems (such as digital breast tomosynthesis), analog systems, and biopsy systems.             

Mammography Devices Market Dynamics

Drivers

• Increasing Incidence of Breast Cancer      

As breast cancer remains one of the most common cancers affecting women worldwide, the need for effective screening methods is more crucial than ever. Mammography is a proven technique for early detection, which is vital for successful treatment outcomes. According to the Mammography Quality Standards Act (MQSA) National Statistics of the U.S., as of August 2022, there were approximately 39.5 million mammography procedures, compared to 38.6 million procedures in August 2021. Consequently, healthcare systems and providers are increasingly prioritizing the adoption of advanced mammography devices to meet the growing demand for reliable diagnostic solutions. This surge in breast cancer cases underscores the critical role of mammography devices in enhancing early diagnosis and improving patient survival rates. The rising incidence of breast cancer globally is significantly driving the demand for early detection and diagnostic tools, including mammography devices.     

• Rising Healthcare Expenditure    

With government and private entities allocating more resources to improve healthcare facilities, there is a growing emphasis on incorporating state-of-the-art diagnostic equipment. Advanced mammography devices, with their enhanced imaging capabilities and diagnostic accuracy, are becoming integral components of modern healthcare setups. This trend is particularly evident in developed regions, where substantial healthcare budgets support the continuous upgrade of medical technologies. The rising healthcare expenditure thus fosters the growth of the mammography devices market by ensuring that healthcare providers have access to the latest diagnostic tools. Increasing investments in healthcare infrastructure and services are leading to the widespread adoption of advanced mammography devices in hospitals and clinics.

Opportunities

• Technological Innovations in Mammography Technology     

Continuous innovations in mammography technology, such as 3D mammography and digital breast tomosynthesis, are significantly enhancing the accuracy and efficiency of breast cancer detection. These technological advancements allow for more detailed and precise imaging of breast tissue, which helps in identifying abnormalities at an earlier stage. 3D mammography, for instance, provides a multi-layered view of the breast, reducing the chances of false positives and negatives. Digital breast tomosynthesis offers a clearer and more comprehensive picture, aiding radiologists in making more accurate diagnoses. These cutting-edge technologies not only improve diagnostic outcomes but also enhance patient comfort and experience, creating new opportunities in the market.       

• Portable and Affordable Mammography Devices  

Developing portable and cost-effective mammography devices can significantly enhance accessibility, particularly in underserved regions. In many parts of the world, especially in rural and low-income areas, access to advanced medical imaging equipment is limited. Portable mammography devices can bridge this gap by providing mobile screening solutions that can be deployed in remote locations. Additionally, making these devices more affordable ensures that a larger segment of the population can benefit from early breast cancer detection. These innovations in portability and affordability are crucial for expanding the reach of mammography services and improving public health outcomes.

Restraints/Challenges

• Radiation Exposure Concerns     

The potential risks associated with radiation exposure during mammography can deter some women from undergoing regular screenings. Despite the low levels of radiation used in mammography, concerns about cumulative exposure and its long-term effects can lead to hesitancy among patients. This apprehension can negatively impact the uptake of mammography screening programs, ultimately affecting early detection rates and challenging the market growth.        

• High Cost of Mammography Devices  

The mammography device price can be a significant barrier for healthcare facilities, particularly in developing regions. State-of-the-art mammography systems, while offering superior imaging capabilities, often come with substantial price tags that can strain the budgets of hospitals and clinics with limited financial resources. This financial hurdle can impede the widespread adoption of advanced diagnostic tools, restricting access to high-quality breast cancer screening for many patients.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In June 2024, the Healthcare Division of FUJIFILM India, in partnership with NM Medical Mumbai, launched its first Fujifilm Skill Lab. This initiative aims to provide advanced training in full-field digital mammography (FFDM) technologies for radiologists and radiographers. The inaugural session was attended by eight participants, including four radiologists and four radiographers           
• In September 2023, Siemens Healthineers introduced the Mammomat B.brilliant1, a new mammography system featuring wide-angle tomosynthesis. This system boasts the largest angle available on the market, with the tube moving around the breast at a 50° angle. Coupled with a scan time of approximately five seconds, it offers the fastest wide-angle tomosynthesis available, producing high-resolution 3D images with remarkable depth in minimal time

Mammography Devices Market Scope

The market is segmented on the basis of device type and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Device Type

• Analog
• Digital
  • Full Field Systems
  • Breast Tomosynthesis Systems
  • Combination Systems
• Others

End User

• Hospitals
• Specialty Clinics
• Diagnostic Centers

Mammography Devices Market Regional Analysis/Insights

The market is analyzed and market size insights and trends are provided by country, device type, and end user as referenced above.

The countries covered in the market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America.

North America is expected to dominate the market due to the increasing incidence of breast cancer, a growing female population, heightened awareness of preventive breast cancer screenings, rising healthcare expenditures, and the expanding healthcare sector in the region.     

Espera-se que a Ásia-Pacífico testemunhe um crescimento significativo durante o período de previsão devido à elevada prevalência do cancro da mama, aos avanços nas tecnologias de imagem da mama e à crescente consciencialização sobre os exames preventivos do cancro da mama.

A secção do país do relatório também fornece fatores individuais de impacto no mercado e alterações na regulamentação do mercado interno que impactam as tendências atuais e futuras do mercado. Pontos de dados como a análise da cadeia de valor a jusante e a montante, tendências técnicas e análise das cinco forças de Porter, estudos de caso são alguns dos indicadores utilizados para prever o cenário de mercado para países individuais. Além disso, são considerados a presença e disponibilidade de marcas globais e os desafios enfrentados devido à grande ou escassa concorrência de marcas locais e nacionais, o impacto das tarifas nacionais e das rotas comerciais, ao mesmo tempo que se fornece uma análise de previsão dos dados do país.

Base instalada de crescimento da infraestrutura de saúde e penetração de novas tecnologias

O mercado também fornece análises de mercado detalhadas para o crescimento de cada país em despesas de saúde para equipamentos de capital, base instalada de diferentes tipos de produtos para o mercado, impacto da tecnologia utilizando curvas de linha de vida e mudanças nos cenários regulamentares de saúde e o seu impacto no mercado. Os dados estão disponíveis para o período histórico 2016-2021.

Análise do panorama competitivo e da quota de mercado dos dispositivos de mamografia

O cenário competitivo do mercado fornece detalhes por concorrente. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, presença global, localizações e instalações de produção, capacidades de produção, pontos fortes e fracos da empresa , lançamento de produto, largura e amplitude do produto, aplicação domínio. Os dados acima fornecidos estão apenas relacionados com o foco das empresas em relação ao mercado.

Alguns dos principais players que operam no mercado são:

• FUJIFILM Holdings Corporation (Japão)
• (EUA)
• Siemens Healthcare Private Limited (Alemanha)
• PLANMED OY (Finlândia)
• Metaltronica SpA (Itália)
• AURORA HEALTHCARE US CORP (EUA)
• CANON MEDICAL SYSTEMS CORPORATION (Japão)
• Corporação Analógica (EUA)
• Carestream Saúde (EUA)
• Companhia General Electric (EUA)
• Koninklijke Philips NV (Holanda)
• CMR Naviscan (EUA)
• Delphinus Medical Technologies, Inc.
• Tecnologias KUB (EUA)
• Micrima Limited (Reino Unido)
• SonoCiné (EUA)
• Imagine Supersónico (França)

SKU-1358